SEC Form 4 · accession 0001209191-18-030360
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert D. Bolles
Director
Period of report
May 12, 2018
Accepted (ET)
May 15, 2018 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $9.16 | May 12, 2018 | A | 8,210 | A | May 12, 2019 | May 12, 2028 | Common Stock | 8,210 | 8,210 | D |
Explanation of responses
- F1The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date.